Study of the Effectiveness of the PALLAS Laser in the Treatment of Skin Diseases That Respond Well to UV Light

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary objective of this study is to get clinical experiences with the PALLAS laser in the treatment of skin conditions that respond well to UV light (vitiligo, psoriasis, alopecia areata, atopic dermatitis). The secondary objective is to assess how user-friendly is the Pallas laser in the treatment of skin diseases. The patient in the trial will receive UVB laser treatment (2 treatments per week for up to 3 months). The treatments will be carried out by the doctors participating in the trial. The treatment takes approximately 10 minutes per session, and can last up to 3 months per patient. Photographic documentation of the lesions to be treated and the lesions treated is taken at the start of the examination and then once a month. At the end of the study, the patient rates the treatment and improvement on a Patient Satisfaction Scale.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• The subject understands the information provided, gives informed consent to participate in the study and is deemed by the investigator to be able to participate,

• a skin condition that is expected to respond well to targeted UVB treatment,

• a signed consent form.

Locations
Other Locations
Hungary
University of Szeged, Albert Szent-Györgyi Clinical Centre, Department of Dermatology and Allergology
RECRUITING
Szeged
Contact Information
Primary
Lajos Kemény, professor, MD, DSc, MHAS
kemeny.lajos@med.u-szeged.hu
+36305152884
Time Frame
Start Date: 2025-12-10
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 50
Treatments
Other: Pallas Laser treated
UVB treated patients
Sponsors
Leads: Szeged University

This content was sourced from clinicaltrials.gov